NASA Astronaut Don Pettit to Discuss Seven-Month Space Mission
WASHINGTON, April 23, 2025 /PRNewswire/ — Media are invited to a news conference at 2 p.m. EDT Monday, April 28, at NASA's Johnson Space Center in Houston where astronaut Don Pettit will share details of his recent mission aboard the International Space Station.
The news conference will stream live on NASA's website. Learn how to stream NASA content through a variety of platforms.
To participate in person, U.S. media must contact the NASA Johnson newsroom no later than 5 p.m. Thursday, April 24, at 281-483-5111 or jsccommu@mail.nasa.gov. Media wishing to participate by phone must contact the newsroom no later than two hours before the start of the event. To ask questions by phone, media must dial into the news conference no later than 10 minutes prior to the start of the call. NASA's media accreditation policy is available online.
Questions also may be submitted on social media during the news conference by using #AskNASA. Following the news conference, NASA will host a live question and answer session with Pettit on the agency's Instagram. For more information, visit @NASA on social media.
Pettit returned to Earth on April 19 (April 20, Kazakhstan time), along with Roscosmos cosmonauts Alexey Ovchinin and Ivan Vagner. Pettit celebrated his 70th birthday on April 20. He spent 220 days in space as an Expedition 71/72 flight engineer, bringing his career total to 590 days in space during four spaceflights. Pettit and his crewmates completed 3,520 orbits of Earth over the course of their 93-million-mile journey. They also saw the arrival of six visiting spacecraft and the departure of seven.
During his time on orbit, Pettit conducted hundreds of hours of scientific investigations, including research to enhance on-orbit metal 3D printing capabilities, advance water sanitization technologies, explore plant growth under varying water conditions, and investigate fire behavior in microgravity, all contributing to future space missions.
He also spent time aboard the space station sharing his photography, often posting images to his X account. He took more than 670,000 photos during his stay.
Learn more about International Space Station research and operations at:
http://www.nasa.gov/station
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
6 hours ago
- The Sun
Trump-Musk showdown threatens US space plans
WASHINGTON: SpaceX's rockets ferry US astronauts to the International Space Station. Its Starlink satellite constellation blankets the globe with broadband, and the company is embedded in some of the Pentagon's most sensitive projects, including tracking hypersonic missiles. So when President Donald Trump threatened on Thursday to cancel Elon Musk's federal contracts, space watchers snapped to attention. Musk, the world's richest person, shot back that he would mothball Dragon -- the capsule NASA relies on for crew flights -- before retracting the threat a few hours later. For now, experts say mutual dependence should keep a full-blown rupture at bay, but the episode exposes just how disruptive any break could be. Founded in 2002, SpaceX leapfrogged legacy contractors to become the world's dominant launch provider. Driven by Musk's ambition to make humanity multiplanetary, it is now NASA's sole means of sending astronauts to the ISS -- a symbol of post-Cold War cooperation and a testbed for deeper space missions. - Space monopoly? - The company has completed 10 regular crew rotations to the orbiting lab and is contracted for four more, under a deal worth nearly $5 billion. That's just part of a broader portfolio that includes $4 billion from NASA for developing Starship, the next-generation megarocket; nearly $6 billion from the Space Force for launch services; and a reported $1.8 billion for Starshield, a classified spy satellite network. Were Dragon grounded, the United States would again be forced to rely on Russian Soyuz rockets for ISS access -- as it did between 2011 and 2020, following the Space Shuttle's retirement and before Crew Dragon entered service. 'Under the current geopolitical climate, that would not be optimal,' space analyst Laura Forczyk told AFP. NASA had hoped Boeing's Starliner would provide redundancy, but persistent delays -- and a failed crewed test last year -- have kept it grounded. Even Northrop Grumman's cargo missions now rely on SpaceX's Falcon 9, the workhorse of its rocket fleet. The situation also casts a shadow over NASA's Artemis program. A lunar lander variant of Starship is slated for Artemis III and IV, the next US crewed Moon missions. If Starship were sidelined, rival Blue Origin could benefit -- but the timeline would almost certainly slip, giving China, which aims to land humans by 2030, a chance to get there first, Forczyk warned. 'There are very few launch vehicles as capable as Falcon 9 -- it isn't feasible to walk away as easily as President Trump might assume,' she said. Still, the feud could sour Trump on space altogether, she added, complicating NASA's long-term plans. SpaceX isn't entirely dependent on the US government. Starlink subscriptions and commercial launches account for a significant share of its revenue, and the company also flies private missions. The next, with partner Axiom Space, will carry astronauts from India, Poland, and Hungary, funded by their respective governments. - Private power, public risk - But losing US government contracts would still be a major blow. 'It's such a doomsday scenario for both parties that it's hard to envision how US space efforts would fill the gap,' Clayton Swope, deputy director of the Aerospace Security Project at the Center for Strategic and International Studies, told AFP. 'Both sides have every reason to bridge the disagreement and get back to business.' Signs of a rift emerged last weekend, when the White House abruptly withdrew its nomination of e-payments billionaire Jared Isaacman -- a close Musk ally who has twice flown to space with SpaceX -- as NASA administrator. On a recent podcast, Isaacman said he believed he was dropped because 'some people had some axes to grind, and I was a good, visible target.' The broader episode could also reignite debate over Washington's reliance on commercial partners, particularly when one company holds such a dominant position. Swope noted that while the US government has long favored buying services from industry, military leaders tend to prefer owning the systems they depend on. 'This is just another data point that might bolster the case for why it can be risky,' he said. 'I think that seed has been planted in a lot of people's minds -- that it might not be worth the trust.'
Malay Mail
18 hours ago
- Malay Mail
Inside the intricate science, engineering, and policy hurdles shaping Nasa, SpaceX's bid to send humans to Mars
WASHINGTON, June 6 — A crewed mission to Mars would rank among the most complex and costly undertakings in human history—and US President Donald Trump has vowed to make it a national priority. That political momentum, coupled with SpaceX chief Elon Musk's zeal, has breathed new life into a cause long championed by Red Planet advocates—even as major obstacles remain, including Trump and Musk's latest feud. Why go? As Nasa writes in its Moon to Mars blueprint, 'exploration of the cosmos remains a great calling for humanity.' A mission to Mars would pursue scientific objectives like determining whether Mars ever hosted life and charting the evolution of its surface, as well as answering broader space physics questions—such as the history of the Sun through studying Martian soil. Geopolitics also looms large, as Trump has pledged to 'plant the American flag on the planet Mars and even far beyond,' invoking the 'unlimited promise of the American dream.' Critics, however, say cuts to Nasa's science budget and the cancellation of key projects—including the return of rock samples collected by the Perseverance rover—are undermining the research mission. 'The purpose of exploration is not just to go somewhere,' Nobel-winning astrophysicist John Mather told AFP. 'This is not a tourist thing. This is a fundamental knowledge thing.' Getting there Musk is betting SpaceX's future on Starship, the largest rocket ever built, despite fiery failures in its nine test flights. He's aiming for an uncrewed launch by late 2026, timed with the next favorable Earth-Mars alignment. But the timeline is widely seen as optimistic: Starship has yet to land its upper stage or demonstrate in-orbit refueling—both essential for deep space travel. Some experts believe the system is fundamentally sound, while others say it's too soon to judge. 'A lot of the pertinent and relevant technical information... is not known to us,' Kurt Polzin, chief engineer for Nasa's space nuclear propulsion project, told AFP. He backs Nuclear Thermal Propulsion (NTP), which uses fission to heat hydrogen and generate thrust. NTP delivers 'a lot of power in a very small package,' Polzin said, eliminating the need for orbital refueling or fuel production on Mars. Astronauts would spend seven to nine months in a cramped spacecraft, exposed to intense space radiation beyond Earth's magnetosphere. Ideas to improve radiation shielding range from passive methods, like using dense materials, to active concepts such as plasma fields that deflect radiation, while drugs are being developed to reduce cell damage. Without a system to simulate gravity—such as rotational spin—crews would also need grueling exercise routines to counteract muscle and bone loss. Mental health is another concern. Growing plants aboard—more for morale than sustenance—has proved beneficial on the ISS. Communication delays further complicate matters. On the station, real-time data has helped prevent an average of 1.7 potentially fatal incidents per year, said Erik Antonsen, chair of NASA's human systems risk board—but such communication will not be possible en route to Mars. Life on Mars Once on the surface, the uncertainties grow. Probes and rovers have found hints—organic molecules, seasonal methane—but no definitive signs of life. If it ever existed, it likely died out long ago. Still, Earth's own 'extremophiles' offer intriguing clues—from fungi that harness Chernobyl's radiation for energy, to microbes that survived 500,000 years in frozen stasis. 'If they can survive here in extreme environments, we have every reason to suspect they can be on Mars,' said NASA astrobiologist Jennifer Eigenbrode at the recent Humans to the Moon and Mars Summit. And while NASA has decided nuclear fission will power surface operations, other choices—from crop selection to habitat design—remain open. 'Mars has a 24-hour, 39-minute day—that small difference creates strain, increases stress, and reduces sleep quality,' said Phnam Bagley, a space architect who designs for comfort and crew well-being—critical factors in preventing conflict. The first trip would be around 500 days on the surface, but long-term colonization raises deeper questions. For instance, scientists don't yet know whether mammalian embryos can develop in low gravity—or what childbirth on Mars would entail. 'I think it's really important to take that seriously,' said NASA's Antonsen. 'Even if you don't plan on it happening, people are still going to have sex, and somebody might get pregnant. Then it becomes a medical issue.' — AFP
Malaysian Reserve
19 hours ago
- Malaysian Reserve
Biodefense Market worth $1.81 billion by 2030
DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ — The biodefense market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period according to a new report by MarketsandMarkets™. The biodefense market is driven by increasing bioterrorism, growing geopolitical tensions, biological warfare risks, and advancements in technology. Biodefense encompasses a range of tools and systems designed to detect, prevent, and respond to biological threats, including infectious diseases, bioterrorism, and accidental pathogen releases. These include biosensors, rapid detection platforms, decontamination systems, mobile containment units, and AI-driven surveillance tools. The market for biodefense technology is experiencing strong growth due to increasing global concerns over pandemics, biological warfare, and emerging infectious diseases. Download PDF Brochure: Browse in-depth TOC on 'Biodefense Market' 196 – Tables56 – Figures217 – Pages Biodefense Market Report Scope: Report Coverage Details Market Revenue in 2025 $ 0.89 billion Estimated Value by 2030 $ 1.81 billion Growth Rate Poised to grow at a CAGR of 15.1% Market Size Available for 2020–2030 Forecast Period 2025–2030 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Technology, Product, Application and Region Geographies Covered North America, Europe, Asia Pacific, and Rest of World Key Market Challenge Infrastructure constraints in low-resource areas Key Market Opportunities Emergence of AI-powered biosurveillance and predictive analytics Key Market Drivers Rising threat of Bioterrorism Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Hospitals are the initial point of contact for the identification of unusual infections or exposure to biological agents, and hence, they must have sophisticated containment systems, sterilization apparatus, and pathogen detection instruments in real time. With increasing bioterrorism, governments and health agencies are investing heavily in the upgrade of hospital biosafety facilities, such as Class III biological safety cabinets, mobile isolation units, and UV sterilization technology, all of which are becoming essential for modern biodefense infrastructure. These facilities need safe conditions to work with high-risk pathogens, which fuels the demand for low-temperature sterilizers, decontamination chambers, and air purification. The growing incorporation of digital surveillance platforms and smart biodefense technologies in healthcare facilities further solidifies their role in early detection and quick response, making hospitals & medical institutes the largest application segment of the biodefense market. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period due to its significant contributions toward monitoring real-time pathogens, forecasting, and fast decision-making. AI facilitates the convergence and synthesis of large-scale environmental data and enables early threat detection and quick response coordination. Governments and health organizations globally are increasingly using AI platforms to track bio-threats across borders and to automatically report disease transmission for strategic purposes. Additionally, AI technologies are being integrated into biosensor networks, autonomous disinfecting robots, and predictive modeling applications utilized in hospitals, airports, and military bases. The increasing focus on digitally empowered biodefense infrastructure, coupled with significant investments by public and private sectors, is expected to fuel the growth of the AI segment in the global market. Inquiry Before Buying: Asia Pacific is projected to register the highest CAGR during the forecast period. Asia Pacific is projected to register the highest CAGR in the biodefense industry through the forecast period due to increasing investments in public health infrastructure, infectious disease surveillance, and military biosafety capacities. China, India, Japan, and Australia are comprehensively developing their biodefense capabilities. These countries are investing in mobile biosafety laboratories, near-real-time pathogen detection systems, and next-generation decontamination technologies to anticipate future biological threats. Also, the region is experiencing growth in biotechnology R&D, cross-border health security efforts, and government-backed biodefense programs. The growth of local biotech and med-tech firms is also propelling innovation in AI-powered disease monitoring, biosensors, and portable sterilizers for civilian and military applications. The growing population, susceptibility to zoonotic disease, and proactive policy changes are driving significant growth in the regional biodefense market. STERIS (US), ASP International GmbH (a subsidiary of Fortive) (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK) are the major key players in the biodefense companies. These companies have strong distribution networks across regions like North America, Europe, Asia Pacific, and the Rest of the World. Get 10% Free Customization on this Report: Browse Adjacent Market: Aerospace and Defence Market Research Reports & Consulting Related Reports: Border Security Market by Domain (Land, Maritime, Airborne), Vertical (Military, Homeland Security), System (Surveillance Systems, Detection Systems, Communication Systems, Command and Control Systems), Installation & Region – Global Forecast to 2029 CBRN Defense Market by Type (Chemical, Biological, Radiological, Nuclear, Explosives), Equipment (Protective Wearables, Respiratory Systems, Detection & Monitoring Systems, Decontamination Systems, Simulators, Others), End Use and Region – Global Forecast to 2028 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Web Site: Insight: Source: Logo: View original content:
